IOPtiMate™ – Laser based treatment of Glaucoma surgery

IOPtima Ltd. develops, manufactures and distributes novel surgical treatments for Glaucoma – The IOPtiMateTM

IOPtiMateTM, a commercialized, novel surgical system that enables a non-penetrating, CO2 laser-assisted procedure known as CLASS (CO2 Laser-Assisted Sclerotomy Surgery) to reduce elevated IOP. CLASS is an, automated, easy-to-perform procedure which requires only a short learning curve and provides a safer and more precise alternative to the currently complex and risky glaucoma surgeries. As a result, we believe that IOPtiMate may also enable a wider range of ophthalmic surgeons to perform glaucoma surgeries, and has the potential to replace existing glaucoma medical procedures and drive an increase in the quantity and quality of glaucoma surgeries worldwide.

The Market:
The treatment of glaucoma comprises one of the largest segments in the ophthalmic market. According to a Market Scope study, there are approximately 78 million glaucoma patients worldwide, 10 million of whom are located in the United States. The rate of diagnosis and treatment of glaucoma and ocular hypertension is increasing, particularly in emerging economies where healthcare infrastructure and access to diagnostic and treatment technologies are improving.
If medication does not sufficiently alleviate a patient’s elevated IOP, there are several medical procedures available, ranging from less invasive in-office procedures such as selective laser trabeculoplasty, or SLT, to more invasive surgical procedures such as trabeculectomy to reduce elevated IOP. According to the Glaucoma Research Foundation, SLT is an ineffective long-term solution for reducing elevated IOP and invasive surgical procedures such as trabeculectomy often result in high post-operation complication rates and long recovery times. Clinical studies show that prevalence of early post-operative complications were reported in more than 45% of patients who underwent a trabeculectomy procedure, and more than 40% of the patients reported late post-operative complications.

The Benefits:
Our IOPtiMate is a novel laser-assisted surgical system intended to treat patients with OAG. It is the only surgical laser system that enables a non-penetrating, CO2 laser-assisted medical procedure known as CLASS to reduce elevated IOP. IOPtiMate permits ophthalmic surgeons to perform accurate deep sclerectomy glaucoma surgery, which reduces elevated IOP by thinning the sclera without penetrating the eyeball. CLASS is an, automated, easy-to-perform procedure which requires only a short learning curve and provides a safer and more precise alternative to the currently complex and risky glaucoma surgeries. As a result, we believe that IOPtiMate may also enable a wider range of ophthalmic surgeons to perform glaucoma surgeries, and has the potential to replace existing glaucoma medical procedures and drive an increase in the quantity and quality of glaucoma surgeries worldwide. The CLASS procedure requires only local anesthesia and is performed as an outpatient procedure. Over 1,500 CLASS procedures have already been conducted using our IOPtiMate system worldwide to date. IOPtiMate can be combined with any ophthalmic microscope in ophthalmology operating rooms.

Key Benefits:

  • Minimally-invasive
  • Excellent safety profile
  • Long-term efficacy
  • Reduces reliance on drug compliance
  • Simple to perform, outpatient module
  • Reproducible results

 

Link to www.ioptimate.co.il

Link to IOPtiMate movie